Hardman Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis
- Written by Hardman & Co Research
LONDON, UK - EQS Newswire - 10 June 2022 - Financial information from over 100 multinational drug companies, involving over 70,000 data points, have been accumulated over the past 35 years to create a pharmaceutical database. All our data (sales, COGS, SG&A, R&D and other income) have been derived from annual reports, regulatory filings...
